Lakewood-amedex Biotherapeutics Inc. · NASDAQ:LABT
LINDESFARNE LLC reported a 9.88% stake in Lakewood-amedex Biotherapeutics Inc. (Schedule 13G)
Event Apr 17, 2026 · Filed Aug 6, 2026
LINDESFARNE LLC reported a 9.88% stake in Lakewood-amedex Biotherapeutics Inc., 203,360 shares, as a passive investor on Apr 17, 2026. Filed Aug 6, 2026 (Schedule 13G).
- Stake
- 9.88%
- Shares
- 203,360
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| LINDESFARNE LLC | 9.88% | 203,360 |